ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0016525;negative regulation of angiogenesis;8.0;0.811012628672052;0.780506314336026;9.32314260294094;151.1079732353669;5.192106149009898;0.005057447875840929;0.6405245499179943;[CXCL10]
GO:1903487;regulation of lactation;6.0;0.8653626801206646;0.7558016526504768;9.461470167828956;54.96887503668497;8.16763571524637;0.0018397587787020977;0.7408135829017477;[OAS2]
GO:1901740;negative regulation of myoblast fusion;9.0;1.0;0.896240625180289;9.628524252492122;353.26084893783826;8.67846133901236;0.011823322699826135;0.8400575416471059;[CXCL10]
GO:0045648;positive regulation of erythrocyte differentiation;8.0;0.9326813400603323;0.8413406700301662;9.582004236857228;358.80145150428314;6.409777797693995;0.012008761681506467;0.7027963346592216;[ISG15]
GO:0010819;regulation of T cell chemotaxis;10.0;0.9326813400603323;0.8815816818910864;9.574457031221845;194.94068539511468;7.292166977892469;0.006524489304947852;0.7881627702307852;[CXCL10]
GO:0010818;T cell chemotaxis;8.0;0.8436909121759173;0.7968454560879586;9.446202695698167;127.60944988880927;7.292166977892469;0.004270973446729658;0.747921758369865;[CXCL10]
GO:0045892;negative regulation of transcription, DNA-templated;10.0;0.556709148698489;0.6935955862101648;8.520155788878647;1581.2569993850602;2.683669001811703;0.05292324873051003;0.5524839694169422;[TRIM6]
GO:0006958;complement activation, classical pathway;8.0;1.0;0.875;9.628524252492122;171.02669507306572;4.7081694254602375;0.005724109570062889;0.6157760033703056;[SERPING1]
GO:0033138;positive regulation of peptidyl-serine phosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;5.152100814396198;0.026061291479152104;0.6787196871063318;[TRIM6]
GO:0070206;protein trimerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;5.8650506222523235;0.00140677858073304;0.6230592741648748;[TRIM6]
GO:0006612;protein targeting to membrane;10.0;0.811012628672052;0.8207473261969463;9.414950152194063;149.73401455281405;4.753193106834193;0.0050114627152184205;0.6583195283905053;[RTP4]
GO:0061844;antimicrobial humoral immune response mediated by antimicrobial peptide;6.0;1.0;0.8231203125901445;9.628524252492122;44.28377145688295;5.682729065458369;0.0014821379778550245;0.6137353412716126;[CXCL10]
GO:0098586;cellular response to virus;6.0;0.7763722522362496;0.7113064387082693;8.999915593069748;28.654098265158677;6.375876246018314;9.59026881920657E-4;0.6491829203200885;[TRIM6]
GO:2000406;positive regulation of T cell migration;10.0;0.7980440201809971;0.8142630219514189;9.461470167828956;351.7821234142529;6.518977089658987;0.011773831087318304;0.7486218033895181;[CXCL10]
GO:1901509;regulation of endothelial tube morphogenesis;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;45.7200117395938;8.390779266560578;0.0015302076475850206;0.7522251544931926;[CXCL10]
GO:0071360;cellular response to exogenous dsRNA;7.0;1.0;0.8509193652572005;9.628524252492122;172.52541059605554;7.069023426578259;0.005774270229860956;0.7124295520356204;[IFIT1]
GO:0046597;negative regulation of viral entry into host cell;8.0;0.9326813400603323;0.8413406700301662;9.548481544818586;84.95196338807416;6.832634648514029;0.002843265762795464;0.7244212536750128;[IFITM3]
GO:0045662;negative regulation of myoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.62387697121986;6.518977089658987;0.0038363580074348307;0.6565011041187423;[CXCL10]
GO:0051097;negative regulation of helicase activity;6.0;0.8653626801206646;0.7558016526504768;9.427853557029971;49.94359093049245;8.390779266560578;0.0016715670421299067;0.7522251544931926;[IFIT1]
GO:0030816;positive regulation of cAMP metabolic process;10.0;0.8259837884571596;0.8282329060895002;9.526741558182179;1396.5025295312637;6.139487467954083;0.04673968289273128;0.7292146864874571;[CXCL10]
GO:0050689;negative regulation of defense response to virus by host;8.0;1.0;0.875;9.628524252492122;351.96651544657516;8.16763571524637;0.011780002522698075;0.7926932703116032;[IFIT1]
GO:0050688;regulation of defense response to virus;6.0;0.7508913569872202;0.6985659910837546;9.193206181234276;71.29061093166123;5.557565922504363;0.002386032590498313;0.6073344923202633;[HERC5, TRIM6, IFIT1]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[IFIT3]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[CXCL10]
GO:0007597;blood coagulation, intrinsic pathway;6.0;1.0;0.8231203125901445;9.628524252492122;55.78978942234946;6.943860283624253;0.0018672340444153065;0.6782296504172152;[SERPING1]
GO:0043367;CD4-positive, alpha-beta T cell differentiation;8.0;0.7763722522362496;0.7631861261181248;9.310070521373587;117.17127606415333;6.641579411751319;0.003921617162564973;0.7146506799819907;[RSAD2]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[CXCL10]
GO:0060700;regulation of ribonuclease activity;7.0;0.7980440201809971;0.7499413753476991;9.392135474427892;157.94414464943608;7.57984905034425;0.005286248380914984;0.738553198190834;[OAS1, OAS2, OAS3, OASL]
GO:0042832;defense response to protozoan;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;69.6526388451159;6.832634648514029;0.0023312111388408135;0.6725415662651573;[BATF2]
GO:0002576;platelet degranulation;8.0;1.0;0.875;9.628524252492122;39.85546922145481;4.956792062075433;0.0013339266872485146;0.6284905765689417;[SERPING1]
GO:0019060;intracellular transport of viral protein in host cell;11.0;1.0;0.9324289523296623;9.628524252492122;185.43516432665677;9.083926447120524;0.006206348069200128;0.8969813732811862;[IFIT1]
GO:0034605;cellular response to heat;5.0;0.8436909121759173;0.712086467948879;9.260799472366804;50.43140892920004;5.666199763507158;0.0016878938715389536;0.5800107312719123;[CXCL10]
GO:0043011;myeloid dendritic cell differentiation;6.0;0.8933024483968273;0.7697715367885581;9.4949928598676;91.1712242271392;6.8867018697843045;0.003051418826107602;0.6753065664753021;[BATF2]
GO:0016079;synaptic vesicle exocytosis;9.0;0.8436909121759173;0.8180860812682478;9.510741216835738;175.934860638427;5.885253329569843;0.0058883814544733026;0.6972127541467594;[OTOF]
GO:0019985;translesion synthesis;9.0;0.8933024483968273;0.8428918493787028;9.572954401337311;760.2225735865501;6.063501560976162;0.025443965382044766;0.706328376990269;[ISG15]
GO:0010994;free ubiquitin chain polymerization;7.0;1.0;0.8509193652572005;9.628524252492122;46.126504921393284;8.16763571524637;0.0015438126085597365;0.7686126355688037;[TRIM6]
GO:0000209;protein polyubiquitination;10.0;0.7671156992804218;0.7987988615011312;9.223059144383958;155.4032479663248;4.243684138952949;0.005201206855589802;0.6322632160784685;[HERC5, TRIM6]
GO:0034165;positive regulation of toll-like receptor 9 signaling pathway;9.0;0.9326813400603323;0.8625812952104552;9.590783924509275;505.2767808384828;9.083926447120524;0.01691115913508416;0.8607930461318132;[RSAD2]
GO:0032020;ISG15-protein conjugation;7.0;1.0;0.8509193652572005;9.628524252492122;151.15475272427284;7.9853141584524145;0.005059013543235805;0.7592887026755414;[HERC5, ISG15]
GO:0002230;positive regulation of defense response to virus by host;8.0;1.0;0.875;9.628524252492122;73.08237040089334;6.599019797332524;0.0024460011674546805;0.712474179321389;[TRIM6]
GO:0051281;positive regulation of release of sequestered calcium ion into cytosol;13.0;0.8933024483968273;0.9092061889660501;9.585964638073326;905.0686146861244;6.139487467954083;0.03029183202467376;0.7765286393941734;[CXCL10]
GO:0002741;positive regulation of cytokine secretion involved in immune response;10.0;1.0;0.9152410118609203;9.628524252492122;980.5172466015069;7.9853141584524145;0.03281702983552129;0.8236103492792612;[TRIM6]
GO:0007517;muscle organ development;4.0;0.7763722522362496;0.6381861261181248;8.753055515138222;27.682183388997124;5.085725745451326;9.264977656821302E-4;0.5100842511328143;[CXCL10]
GO:0030593;neutrophil chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;130.2972973825895;5.382624473008031;0.004360933283440787;0.671508291047556;[CXCL10]
GO:0010800;positive regulation of peptidyl-threonine phosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;778.6672313762616;6.375876246018314;0.026061291479152104;0.7413036195908642;[TRIM6]
GO:0032496;response to lipopolysaccharide;5.0;0.8933024483968273;0.736892236059334;9.446202695698167;64.414971589946;4.086714173356409;0.002155911129404774;0.4992357647380114;[CXCL10, TRIM6]
GO:0034157;positive regulation of toll-like receptor 7 signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;505.2767808384828;9.083926447120524;0.01691115913508416;0.8607930461318132;[RSAD2]
GO:0032897;negative regulation of viral transcription;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;62.48948681665221;6.641579411751319;0.0020914668868664225;0.6905700452391912;[IFITM3]
GO:0003374;dynamin family protein polymerization involved in mitochondrial fission;8.0;1.0;0.875;9.628524252492122;46.126504921393284;7.57984905034425;0.0015438126085597365;0.7626338329336335;[MX1]
GO:0006006;glucose metabolic process;6.0;0.7090535922965819;0.6776471087384355;8.572471578242808;34.676020684410545;5.040875179285974;0.0011605752059146955;0.5809109036834981;[OAS1]
GO:0042730;fibrinolysis;9.0;1.0;0.896240625180289;9.628524252492122;252.8988266382142;6.7325511899570465;0.008464296133413719;0.740543606130341;[SERPING1]
GO:0032091;negative regulation of protein binding;5.0;0.6997970393407541;0.6401395315312973;8.48339194818912;32.716075545242866;5.171903441692378;0.0010949776059428606;0.5547323943871747;[IFIT1]
GO:0006401;RNA catabolic process;7.0;0.5945822691631375;0.6482104998387692;8.775746926340293;532.6118641417924;4.304802954008995;0.01782603977326812;0.5710671885190304;[OAS2]
GO:2000679;positive regulation of transcription regulatory region DNA binding;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;47.96814533750694;6.641579411751319;0.0016054506559182917;0.6627709925721352;[TRIM6]
GO:0043154;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;12.0;0.8653626801206646;0.8808016526504769;9.556203590912496;734.4861809891323;5.277263957350204;0.024582591483058774;0.7179998367869053;[LAMP3]
GO:0001869;negative regulation of complement activation, lectin pathway;11.0;0.9326813400603323;0.8987696223598284;9.608721625195942;1800.6019443914147;9.083926447120524;0.060264526642238345;0.8969813732811862;[SERPING1]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[IFITM3, RTP4, RSAD2, MX1, ISG15, IFIT1, IFIT3, IFI44L, OASL, HERC5, CXCL10, OAS1, OAS2, OAS3]
GO:0031397;negative regulation of protein ubiquitination;10.0;0.7508913569872202;0.7906866903545304;9.372590878354922;529.4632463014641;5.572381008289503;0.01772065836772442;0.7002128357670632;[ISG15]
GO:0030501;positive regulation of bone mineralization;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;171.85898464291293;6.221725566191056;0.005751965552953692;0.6690987000520388;[ISG15]
GO:0051205;protein insertion into membrane;7.0;0.7436939687323844;0.7227663496233927;9.081980546124052;54.49928435303714;6.641579411751319;0.0018240420011245825;0.6905700452391912;[RTP4]
GO:2000553;positive regulation of T-helper 2 cell cytokine production;10.0;1.0;0.9152410118609203;9.628524252492122;874.8811381751227;7.9853141584524145;0.029281484352815565;0.8236103492792612;[RSAD2]
GO:0032480;negative regulation of type I interferon production;6.0;0.7980440201809971;0.722142322680643;9.186691500213083;65.25422870398782;6.015873511986907;0.002184000309729388;0.6307723637598831;[HERC5, ISG15]
GO:0045859;regulation of protein kinase activity;9.0;0.5608425510848448;0.6766619007227115;8.333797084897721;159.5555227474585;3.0974744418360864;0.005340179755709658;0.5546456121830788;[HERC5, CXCL10]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[CXCL10]
GO:0090026;positive regulation of monocyte chemotaxis;10.0;1.0;0.9152410118609203;9.628524252492122;859.35541097108;6.8867018697843045;0.028761852235543582;0.7674272657460779;[CXCL10]
GO:0043950;positive regulation of cAMP-mediated signaling;8.0;0.8436909121759173;0.7968454560879586;9.517298617381897;239.5163045814748;6.686031174322154;0.008016395163662574;0.7169239451870815;[CXCL10]
GO:1901799;negative regulation of proteasomal protein catabolic process;10.0;0.7980440201809971;0.8142630219514189;9.483342242647623;1665.26152136704;5.905872616772578;0.05573480448208542;0.7172676121338334;[LAMP3]
GO:0042742;defense response to bacterium;6.0;0.7866048967936545;0.7164227609869718;9.193206181234276;69.6526388451159;4.021331414093558;0.0023312111388408135;0.5287713881179241;[ISG15]
GO:0006139;nucleobase-containing compound metabolic process;4.0;0.2927628446114555;0.39638142230572776;5.401027157282536;96.27736604478845;1.3632429492593854;0.0032223167975150343;0.31971630782240534;[BATF2, OAS2, OAS3, ISG15, HES4]
GO:0000266;mitochondrial fission;5.0;1.0;0.7902410118609202;9.628524252492122;40.48578058269761;6.686031174322154;0.0013550226412659145;0.6321649570480018;[MX1]
GO:0007219;Notch signaling pathway;6.0;0.7763722522362496;0.7113064387082693;8.866384200445225;26.50247477320489;4.99795013456894;8.87013979980389E-4;0.5787157149004503;[HES4]
GO:0001756;somitogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;43.80328827915336;5.845247994956144;0.0014660566383032007;0.5891672661548076;[HES4]
GO:0010628;positive regulation of gene expression;6.0;0.4705935272257725;0.5584170762030307;6.666693530613812;58.797024432214236;2.2471302570788807;0.001967883493859682;0.43803865843940215;[CXCL10, TRIM6, LAMP3]
GO:0010506;regulation of autophagy;6.0;0.6260725219892441;0.6361565735847665;8.273978589686811;43.35793677134884;4.08334148887777;0.001451151124127319;0.5319425862261522;[LAMP3]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[CXCL10]
GO:0050767;regulation of neurogenesis;6.0;0.47270034079162526;0.5594704829859571;7.335989495351577;60.464536800347794;3.1570004211501135;0.002023693632157412;0.4845694609432947;[HES4]
GO:0033280;response to vitamin D;7.0;0.9326813400603323;0.8172600352873667;9.548481544818586;74.55580141320215;6.375876246018314;0.002495315577434836;0.6769819729871445;[CXCL10]
GO:0060340;positive regulation of type I interferon-mediated signaling pathway;8.0;1.0;0.875;9.628524252492122;527.9279232538245;7.379178354882098;0.017669272487020958;0.7523715242355574;[TRIM6]
GO:0009615;response to virus;5.0;0.7436939687323844;0.6620879962271125;8.801845679307654;27.267803904038782;4.174954806800768;9.126288572378991E-4;0.503748394835965;[IFITM3, RTP4, RSAD2, MX1, IFI44, ISG15, IFIT1, IFIT3, IFI44L, OASL, HERC5, CXCL10, TRIM6, OAS1, OAS2, OAS3]
GO:0000079;regulation of cyclin-dependent protein serine/threonine kinase activity;11.0;0.7866048967936545;0.8257314007264895;9.474373572664863;340.6851601099881;5.181953777545879;0.011402425712143147;0.6974343094988531;[HERC5]
GO:2000737;negative regulation of stem cell differentiation;6.0;0.7586651285174919;0.7024528768488905;9.136047767394327;115.31702415177813;6.781341354126479;0.0038595570197761534;0.6699184248047958;[TRIM6]
GO:0010951;negative regulation of endopeptidase activity;10.0;0.7671156992804218;0.7987988615011312;9.446202695698167;500.3238742612354;4.2676852910524925;0.016745389809270216;0.6334906361130068;[LAMP3, SERPING1]
GO:0071357;cellular response to type I interferon;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;9.777073627680469;0.0027327542132076126;0.8231203125901445;[IFIT1]
GO:0045070;positive regulation of viral genome replication;8.0;0.8933024483968273;0.8216512241984136;9.474373572664863;85.31211810933421;6.221725566191056;0.0028553198171978322;0.6931793347948383;[IFIT1]
GO:0045071;negative regulation of viral genome replication;8.0;0.8933024483968273;0.8216512241984136;9.474373572664863;85.23964546052278;5.8067817141283475;0.0028528942228632634;0.6719590869034888;[IFITM3, TRIM6, RSAD2, OAS1, OAS3, MX1, ISG15, IFIT1, OASL]
GO:0019941;modification-dependent protein catabolic process;7.0;0.7140352122741334;0.7079369713942671;9.076455670192082;155.06587648199024;3.572515865111779;0.005189915335623747;0.5336179927379946;[ISG15]
GO:0035457;cellular response to interferon-alpha;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;7.474488534686424;0.0027327542132076126;0.7053660038532718;[IFIT3]
GO:0035458;cellular response to interferon-beta;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;7.004484905440688;0.0027327542132076126;0.6813299963962409;[TRIM6]
GO:0060333;interferon-gamma-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.514393750639154;0.00101047745553359;0.6329257181104212;[OAS1, OAS2, OAS3, OASL]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[BATF2, HES4]
GO:0050709;negative regulation of protein secretion;8.0;0.6493065804076676;0.6996532902038338;8.749274792298316;381.9718045319581;5.058574756385375;0.01278425254537885;0.6336957482893315;[RSAD2]
GO:0001580;detection of chemical stimulus involved in sensory perception of bitter taste;6.0;1.0;0.8231203125901445;9.628524252492122;24.998545608763582;6.063501560976162;8.36678824294913E-4;0.6332080644001243;[RTP4]
GO:0007166;cell surface receptor signaling pathway;5.0;0.43360584258713153;0.507043933154486;5.906854975555195;23.17027026302992;2.006850423521684;7.75488093814194E-4;0.39287143584790796;[IFITM3, RSAD2, MX1, ISG15, IFIT1, IFIT3, OASL, CXCL10, OAS1, OAS2, OAS3, XAF1, HES4, LY6E]
GO:0060337;type I interferon signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.587418885654044;0.00101047745553359;0.6366602269110988;[IFITM3, RSAD2, OAS1, OAS2, OAS3, MX1, ISG15, IFIT1, XAF1, IFIT3, OASL]
GO:0006357;regulation of transcription by RNA polymerase II;10.0;0.43649654099988644;0.6334892823608635;7.109131426632953;248.56913769389934;1.8913682364374496;0.008319385340914571;0.5119656714299493;[BATF2, CXCL10, HES4]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[CXCL10]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[LAMP3, IFIT3]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[HERC5, MX1, SERPING1]
GO:0070098;chemokine-mediated signaling pathway;7.0;0.7307253602413294;0.7162820453778652;8.999915593069748;30.19135422731818;5.459585514144159;0.00101047745553359;0.6301228223472235;[CXCL10]
